Which medications in the drug class Antineoplastics, Anti-CD20 Monoclonal Antibodies are used in the treatment of Acquired Angioedema Due to C1 Inhibitor Deficiency?

Updated: May 20, 2020
  • Author: Amanda T Moon, MD; Chief Editor: William D James, MD  more...
  • Print

Antineoplastics, Anti-CD20 Monoclonal Antibodies

The agents in this class target specific antigens in carcinoma cells and induce cytotoxicity.

Rituximab (Rituxan)

Rituximab is a humanized monoclonal antibody. It binds to the CD20 antigen, inducing complement- or antibody-mediated cytolysis. Variable treatment regimens have been used to treat acquired angioedema.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!